Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medicinova (MNOV) Income from Continuing Operations (2021 - 2025)

Medicinova (MNOV) has disclosed Income from Continuing Operations for 7 consecutive years, with 7275181.0 as the latest value for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations changed N/A to 7275181.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 2579308.0, a N/A change, with the full-year FY2025 number at 6827.0, up 100.06% from a year prior.
  • Income from Continuing Operations was 7275181.0 for Q4 2025 at Medicinova, up from 3380998.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 7275181.0 in Q4 2025 to a low of 3607092.0 in Q2 2025.
  • A 5-year average of 1107565.5 and a median of 2793546.5 in 2023 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: crashed 1945.77% in 2022, then rose 27.23% in 2023.
  • Medicinova's Income from Continuing Operations stood at 6826044.0 in 2021, then crashed by 149.41% to 3372673.0 in 2022, then surged by 69.23% to 1037808.0 in 2023, then tumbled by 175.7% to 2861281.0 in 2024, then soared by 354.26% to 7275181.0 in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Income from Continuing Operations are 7275181.0 (Q4 2025), 3380998.0 (Q3 2025), and 3607092.0 (Q2 2025).